Gotowe bibliografie tematyczne / Cannabis

Gotowa bibliografia na temat „Cannabis”

Autor: Grafiati
Data publikacji: 4 czerwca 2021
Data aktualizacji: 28 lipca 2024

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Spis treści

Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Cannabis”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Artykuły w czasopismach na temat "Cannabis"

1

Harishchandra, Dulanjalee Lakmali, Sukanya Haituk, Patchareeya Withee, Nisachon Tamakaew, Nittaya Nokum, Chaorai Kanchanomai, Tonapha Pusadee, Chiharu Nakashima i Ratchadawan Cheewangkoon. "First Molecular Phylogenetic Identification and Report of Pseudocercospora cannabina Causing Leaf Spot Disease on Cannabis sativa in Thailand". Horticulturae 9, nr 12 (23.11.2023): 1261. http://dx.doi.org/10.3390/horticulturae9121261.

Pełny tekst źródła
Streszczenie:
Cannabis sativa is gaining attention as an agronomically important crop in many countries around the world. The identification and control of leaf diseases in cannabis are very important for cannabis cultivators as leaves are the most economically important part of the cannabis plants. In 2022, several cannabis plants in cultivations showing olive leaf spot symptoms emerged from Chiang Rai province, Thailand. Preliminary studies indicated that the causal organism is Pseudocercospora sp. Species of Pseudocercospora are important plant pathogens that are now identified through morphological studies combined with DNA sequence data of Internal Transcribed Spacer (ITS), Actin (act), Translation Elongation Factor (tef), and RNA Polymerase II second largest subunit (rpb2) gene regions. We aimed to investigate and understand the emergence of olive leaf spot disease in cannabis plants in Chiang Rai province, Thailand, with a specific focus on the combined morpho-molecular identification of the pathogen. In our study, Pseudocercospora cannabina, the causal organism of olive leaf spot disease, was identified as the leaf spot-causing pathogen with both morphological and phylogenetic analyses. Our study is the first to provide molecular data for Ps. cannabina as the typenor Ps. cannabina isolates from previous studies have made molecular data available for this species. A pathogenicity test, re-isolation, and identification steps were performed to fulfill Koch’s postulates. This comprehensive approach enhances our understanding of the olive leaf spot disease and its causative agent in cannabis.
Style APA, Harvard, Vancouver, ISO itp.
2

Al-Khazaleh, Ahmad K., Xian Zhou, Deep Jyoti Bhuyan, Gerald W. Münch, Elaf Adel Al-Dalabeeh, Kayla Jaye i Dennis Chang. "The Neurotherapeutic Arsenal in Cannabis sativa: Insights into Anti-Neuroinflammatory and Neuroprotective Activity and Potential Entourage Effects". Molecules 29, nr 2 (15.01.2024): 410. http://dx.doi.org/10.3390/molecules29020410.

Pełny tekst źródła
Streszczenie:
Cannabis, renowned for its historical medicinal use, harbours various bioactive compounds—cannabinoids, terpenes, and flavonoids. While major cannabinoids like delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) have received extensive scrutiny for their pharmacological properties, emerging evidence underscores the collaborative interactions among these constituents, suggesting a collective therapeutic potential. This comprehensive review explores the intricate relationships and synergies between cannabinoids, terpenes, and flavonoids in cannabis. Cannabinoids, pivotal in cannabis’s bioactivity, exhibit well-documented analgesic, anti-inflammatory, and neuroprotective effects. Terpenes, aromatic compounds imbuing distinct flavours, not only contribute to cannabis’s sensory profile but also modulate cannabinoid effects through diverse molecular mechanisms. Flavonoids, another cannabis component, demonstrate anti-inflammatory, antioxidant, and neuroprotective properties, particularly relevant to neuroinflammation. The entourage hypothesis posits that combined cannabinoid, terpene, and flavonoid action yields synergistic or additive effects, surpassing individual compound efficacy. Recognizing the nuanced interactions is crucial for unravelling cannabis’s complete therapeutic potential. Tailoring treatments based on the holistic composition of cannabis strains allows optimization of therapeutic outcomes while minimizing potential side effects. This review underscores the imperative to delve into the intricate roles of cannabinoids, terpenes, and flavonoids, offering promising prospects for innovative therapeutic interventions and advocating continued research to unlock cannabis’s full therapeutic potential within the realm of natural plant-based medicine.
Style APA, Harvard, Vancouver, ISO itp.
3

Watson, C. Wei-Ming, Laura M. Campbell, Ni Sun-Suslow, Suzi Hong, Anya Umlauf, Ronald J. Ellis, Jennifer E. Iudicello i in. "Daily Cannabis Use is Associated With Lower CNS Inflammation in People With HIV". Journal of the International Neuropsychological Society 27, nr 6 (lipiec 2021): 661–72. http://dx.doi.org/10.1017/s1355617720001447.

Pełny tekst źródła
Streszczenie:
AbstractObjective:Recent cannabis exposure has been associated with lower rates of neurocognitive impairment in people with HIV (PWH). Cannabis’s anti-inflammatory properties may underlie this relationship by reducing chronic neuroinflammation in PWH. This study examined relations between cannabis use and inflammatory biomarkers in cerebrospinal fluid (CSF) and plasma, and cognitive correlates of these biomarkers within a community-based sample of PWH.Methods:263 individuals were categorized into four groups: HIV− non-cannabis users (n = 65), HIV+ non-cannabis users (n = 105), HIV+ moderate cannabis users (n = 62), and HIV+ daily cannabis users (n = 31). Differences in pro-inflammatory biomarkers (IL-6, MCP-1/CCL2, IP-10/CXCL10, sCD14, sTNFR-II, TNF-α) by study group were determined by Kruskal–Wallis tests. Multivariable linear regressions examined relationships between biomarkers and seven cognitive domains, adjusting for age, sex/gender, race, education, and current CD4 count.Results:HIV+ daily cannabis users showed lower MCP-1 and IP-10 levels in CSF compared to HIV+ non-cannabis users (p = .015; p = .039) and were similar to HIV− non-cannabis users. Plasma biomarkers showed no differences by cannabis use. Among PWH, lower CSF MCP-1 and lower CSF IP-10 were associated with better learning performance (all ps < .05).Conclusions:Current daily cannabis use was associated with lower levels of pro-inflammatory chemokines implicated in HIV pathogenesis and these chemokines were linked to the cognitive domain of learning which is commonly impaired in PWH. Cannabinoid-related reductions of MCP-1 and IP-10, if confirmed, suggest a role for medicinal cannabis in the mitigation of persistent inflammation and cognitive impacts of HIV.
Style APA, Harvard, Vancouver, ISO itp.
4

Ličanin, Ifeta, i Amira Redžić. "Psycho-Social Characteristics of Cannabis Abusing Youth". Bosnian Journal of Basic Medical Sciences 5, nr 1 (20.02.2005): 72–76. http://dx.doi.org/10.17305/bjbms.2005.3339.

Pełny tekst źródła
Streszczenie:
It is a well known fact that drug abuse is most common in early adolescence. The most popular substances among youth are cannabis products (made from Cannabis sativa L., Cannaba-ceae). The majority of heroin and cocaine addicts have started with marijuana. The aim of this study is to show some psycho-social characteristics of adolescents who abuse cannabis. Research conducted during the year 2001 was epidemiological and prospective. The study group included 600 adolescents of equal gender and age distribution. Q 2000 questionnaire was used, as a comprehensive tool for all aspects of adolescent life. The results show strong peer impact on one’s behavior. Youth who use cannabis had 2-3 friends of the same behavior, compared to others who had none. We found positive correlation between life stressful events and cannabis abuse. We also noticed tendency to delinquent behavior related to cannabis abuse (35%).
Style APA, Harvard, Vancouver, ISO itp.
5

Iftikhar, Amna, Umaima Zafar, Waqar Ahmed, Muhammad Asim Shabbir, Aysha Sameen, Amna Sahar, Zuhaib F. Bhat, Przemysław Łukasz Kowalczewski, Maciej Jarzębski i Rana Muhammad Aadil. "Applications of Cannabis Sativa L. in Food and Its Therapeutic Potential: From a Prohibited Drug to a Nutritional Supplement". Molecules 26, nr 24 (20.12.2021): 7699. http://dx.doi.org/10.3390/molecules26247699.

Pełny tekst źródła
Streszczenie:
Hemp (Cannabis sativa L.) is a herbaceous anemophilous plant that belongs to the Cannabinaceae family. The cannabis seed (hemp) has long been utilized as a food source and is commercially important as an edible oil source. In this review, the positive and negative health effects of cannabis, the relationship between cannabis and various diseases, and the use of cannabis in various food products have been discussed. In addition, the scientific literature on the potential use of cannabis and its derivatives as a dietary supplement for the prevention and treatment of inflammatory and chronic degenerative diseases in animals and humans has been reviewed. Cannabis is being developed as a key ingredient in a variety of food items, including bakery, confectionery, beverages, dairy, fruits, vegetables, and meat. Hemp seeds are high in readily digestible proteins, lipids, polyunsaturated fatty acids (PUFA), insoluble fiber, carbs, and favorable omega-6 PUFA acid to omega-3 PUFA ratio and have high nutritional value. The antioxidants of cannabis, such as polyphenols, help with anxiety, oxidative stress, and the risk of chronic illnesses, including cancer, neurological disorders, digestive problems, and skin diseases. Cannabis has been shown to have negative health impacts on the respiratory system, driving, and psychomotor functions, and the reproductive system. Overall, the purpose of this research is to stimulate more in-depth research on cannabis’s adaptation in various foods and for the treatment of chronic illnesses.
Style APA, Harvard, Vancouver, ISO itp.
6

Smith, D. E., i R. B. Seymour. "Cannabis and cannabis withdrawal". Journal of Substance Misuse 2, nr 1 (styczeń 1997): 49–53. http://dx.doi.org/10.3109/14659899709084617.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Hübner, Jutta. "Cannabis, Hanf (Cannabis sativa)". Onkologische Welt 01, nr 05 (2010): 200. http://dx.doi.org/10.1055/s-0038-1632891.

Pełny tekst źródła
Streszczenie:
Cannabis oder Hanf wird im Freiland je nach Sorte zwischen ca. 50 cm bis 8 m hoch, in europäischen Breitengraden maximal ca. 4 m, wobei 2 m als realistisch angesehen werden sollten. Zur medizinischen Verwendung kommt meist der Indische Hanf (Cannabis sativa indica).
Style APA, Harvard, Vancouver, ISO itp.
8

McPartland, John M., i Ethan B. Russo. "Cannabis and Cannabis Extracts". Journal of Cannabis Therapeutics 1, nr 3-4 (czerwiec 2001): 103–32. http://dx.doi.org/10.1300/j175v01n03_08.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Lapierre, Éliana, Maxime de Ronne, Rosemarie Boulanger i Davoud Torkamaneh. "Comprehensive Phenotypic Characterization of Diverse Drug-Type Cannabis Varieties from the Canadian Legal Market". Plants 12, nr 21 (2.11.2023): 3756. http://dx.doi.org/10.3390/plants12213756.

Pełny tekst źródła
Streszczenie:
Cannabis (Cannabis sativa L.) stands as a historically significant and culturally important plant, embodying economic, social, and medicinal relevance for human societies. However, years of prohibition and stigmatization have hindered the cannabis research community, which is hugely undersized and suffers from a scarcity of understanding of cannabis genetics and how key traits are expressed or inherited. In this study, we conducted a comprehensive phenotypic characterization of 176 drug-type cannabis accessions, representative of Canada’s legal market. We assessed germination methods, evaluated various traits including agronomic, morphological, and cannabinoid profiles, and uncovered significant variation within this population. Notably, the yield displayed a negative correlation with maturity-related traits but a positive correlation with the fresh biomass. Additionally, the potential THC content showed a positive correlation with maturity-related traits but a negative correlation with the yield. Significant differences were observed between the plants derived from regular female seeds and feminized seeds, as well as between the plants derived from cuttings and seeds for different traits. This study advances our understanding of cannabis cultivation, offering insights into germination practices, agronomic traits, morphological characteristics, and biochemical diversity. These findings establish a foundation for precise breeding and cultivar development, enhancing cannabis’s potential in the legal market.
Style APA, Harvard, Vancouver, ISO itp.
10

da Costa-Oliveira, Claudete, Michele Lafayette Pereira, Nicole Ferrari de Carvalho, Luiza Aparecida Luna Silvério, Ygor Jessé Ramos i Priscila Gava Mazzola. "Exploring the Significance of Pharmaceutical Care in Mental Health: A Spotlight on Cannabis". Pharmacy 12, nr 4 (27.06.2024): 100. http://dx.doi.org/10.3390/pharmacy12040100.

Pełny tekst źródła
Streszczenie:
Although preliminary evidence suggests Cannabis’s efficacy in symptom control for anxiety and depression—psychiatric disorders that significantly impact mental health—much remains to be understood about its effects on the central nervous system (CNS) and how to optimize treatment for these disorders. This study aims to conduct a narrative review to evaluate pharmaceutical care in treating symptoms of anxiety and depression alongside Cannabis use, focusing on safety and therapeutic efficacy optimization. We seek to conceptualize anxiety and depression disorders, review evidence on Cannabis use, evaluate the evidence quality, and identify knowledge gaps. Twelve articles were identified, revealing a significant gap in the literature regarding the integration of pharmaceutical care with Cannabis-based therapies, specifically for anxiety and depression. Despite a growing interest in the relationship between Cannabis and mental health, current research is insufficient for a comprehensive understanding. The relationship between Cannabis use and anxiety and depression disorders requires further, more targeted investigations. This study underscores the importance of future research to fill existing gaps, providing informed insights and robust guidelines for the safe and effective use of Cannabis as part of the treatment for anxiety and depression. It is crucial that pharmaceutical care integrates these therapies responsibly to improve the overall well-being of patients.
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Rozprawy doktorskie na temat "Cannabis"

1

Lonsdale, Janine M. "Cannabis - related cognitions amongst a clinical sample of cannabis users /". St. Lucia, Qld, 2004. http://www.library.uq.edu.au/pdfserve.php?image=thesisabs/absthe17817.pdf.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Jansson, Mari, i Molly Tally. "Är cannabis den nya folkölen? : Unga cannabisanvändares tal om cannabis". Thesis, Stockholms universitet, Institutionen för socialt arbete - Socialhögskolan, 2015. http://urn.kb.se/resolve?urn=urn:nbn:se:su:diva-118085.

Pełny tekst źródła
Streszczenie:
The aim of this study was to examine young adult cannabis users’ attitudes towards cannabis and their perception of the normalization of cannabis. The purpose was also to explore how their views of cannabis correspond with norms regarding cannabis. This study is based on interviews with five young adult cannabis users. The theoretical framework is based on Parker’s normalization thesis, Goffman’s notion of stigma, Becker’s definition of outsiders and the definition of social identity developed by Stone. The theory of cognitive dissonance was also used to analyze the empirics. The result shows that the interviewees experience a normalization of cannabis, although a process of stigmatization cannot be disregarded. The result also indicates that the respondent’s views of cannabis do not conform to society. The main conclusions are that cannabis is normalized in certain groups, which creates a discrepancy between the attitudes of cannabis users and Swedish society. The reasons for using cannabis are individual and one recurrent explanation is that the respondents experience less negative consequences of cannabis, compared to the effects of alcohol. These findings are supported by earlier research. In order to develop a constructive dialogue about cannabis, the understanding of these attitudes is important for social work.
Style APA, Harvard, Vancouver, ISO itp.
3

Lee, Tiah. "Cannabis Metabolomics: Comparison of Cannabis Products and Effect of Vaporization". Thesis, Université d'Ottawa / University of Ottawa, 2019. http://hdl.handle.net/10393/39706.

Pełny tekst źródła
Streszczenie:
Cannabis is widely consumed medically and recreationally due to the presence of cannabinoids, but the phytochemical complexity of different varieties and preparations is a major knowledge gap. This thesis investigated the phytochemicals present in thirteen different cannabis strains using untargeted and targeted phytochemical analysis to determine “strain” differences in cannabis tinctures and oils. In addition, the phytochemical differences between different oil products, namely oils extracted by ethanol and CO2 supercritical fluid, were also determined to evaluate different processing methods. It was found that inter-strain variability was more significant than the preparation methods due to the strain-specific presence of major cannabinoids, specifically THCA and CBDA. Furthermore, a processing step like drying removed phytochemicals contributing to strain differences, most notably terpenes. The results suggested that consumers can expect different strains and products to have different chemical profiles, as CO2 oils were found to be more chemically consistent across products than tinctures. Cannabis can be consumed in many different ways, and one popular mode of delivery is vaporization. Vaporization extracts active principles of cannabis with heated gas and could lead to a different phytochemical profile compared to the original flower counterpart. Consequently, the product label based on the raw material may not be representative of what is phytochemically available during consumption. The results of this study showed a reduction in available chemicals after vaporizing flower and oils, and little new chemical formation through this process. Decarboxylated cannabinoids were the most significant contributors to differences between pre and post-vaporized samples, and different phytochemistry composition was observed after vaporization. The results also demonstrated that vaporization reduces inter-strain and inter-product chemical diversity, but the content of the vapor can still be affected by the strain used. Furthermore, it showed that vaporization could extract phytochemicals differently from oils than flower material. This thesis provides a new understanding of phytochemical differences, extraction and vaporization processes of cannabis, and provides novel insights into cannabis for producers and consumers. Understanding the differences in chemical content of different types of concentrates can better inform producers and consumers about the products they make, sell and use. In addition, this thesis supports the use of vaporization as a harm reduction method for the consumption of cannabis, and increases understanding of cannabis vaporization. The information from this thesis contributes novel insights into cannabis research and provides a foundation for further studies.
Style APA, Harvard, Vancouver, ISO itp.
4

Vargas, Carlos, i Sandra Miranda. "Cannabis Coffee Shop". Tesis, Universidad de Chile, 2016. http://repositorio.uchile.cl/handle/2250/143146.

Pełny tekst źródła
Streszczenie:
TESIS PARA OPTAR AL GRADO DE MAGÍSTER EN ADMINISTRACIÓN Carlos Vargas [Parte I], Sandra Miranda [Parte II]
En respuesta a la necesidad detectada y no atendida de una parte de la población que se encuentra entre los 20 y 45 años de edad, que trabajan en la comuna de Providencia, en la Región Metropolitana, es que nace Cannabis Coffee Shop (CCS) con el fin de satisfacer la compra de productos cannabicos de colección, en los tiempos libres que se dan en los horarios de trabajo de estas personas, dentro de un lugar moderno, vanguardista y amigable con el medio ambiente, donde además tuvieran la posibilidad de probar productos de cafetería gourmet. Según éste estudio a marzo del 2016, solo hay un competidor, que se encuentra posicionado en la comuna de Santiago, lo que hace de la ubicación de CCS una ventaja competitiva. Debido al proyecto que hoy se encuentra en la Cámara de Diputados sobre el cambio a la ley 20.0001, es que la industria de las cafeterías y growshop2 se ha visto en un constante crecimiento y renovación. Dada la experiencia del equipo gestor de éste estudio, las buenas relaciones con mayoristas claves, las consignaciones con Sweet Fusión con un margen asegurado y pagos a 30 días y el reciente auspicio de Nirvana (marca internacional de semillas de Holanda), preceden el éxito y consolidación al primer año de iniciado CCS. La inversión iniciales es de 983 UF y se espera obtener utilidades por 2000 UF al quinto año, con un valor actual neto (VAN) de 1145 UF y una tasa interna de retorno (TIR) de 47%.
Style APA, Harvard, Vancouver, ISO itp.
5

Arveiller, Catherine Karila Laurent. "Artériopathies et cannabis". Créteil : Université de Paris-Val-de-Marne, 2006. http://doxa.scd.univ-paris12.fr:80/theses/th0240873.pdf.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Alshibiby, Sara, i Snigdha Chowdhury. "CANNABIS - EN KVALITATIV STUDIE OM HUR ANVÄNDNING AV CANNABIS KAN UPPLEVAS". Thesis, Malmö högskola, Fakulteten för hälsa och samhälle (HS), 2013. http://urn.kb.se/resolve?urn=urn:nbn:se:mau:diva-25476.

Pełny tekst źródła
Streszczenie:
The purpose of this paper was to examine how people experience the practice of Cannabis in daily life. The study was based on interviews with five individuals who have experience with cannabis use. They do not represent a bigger population only themselves. We chose these particular individuals because all of them began using cannabis at a young age- everyone before they were twenty. But they have been using cannabis because of different reasons. The results of the interviews were analyzed with the thesis of Howard Becker and the new developed thesis of Hallstone about social control. The thesis explains the pattern of becoming a drug addict and what the steps are. The final results of this study contain answers about how much cannabis they have been using, how often, with whom and with what purpose. We compared these answers to the patterns to see if there was any truth to them and then we explained the function the drug has in their lives. For further explaining we used former researches about cannabis use in different areas of life. In the discussion we try to understand what these answers mean, what the thought behind cannabis use is and if these people really have the control over it.
Style APA, Harvard, Vancouver, ISO itp.
7

Facchin, Michela Keiser-Grassi Paola. "Cannabis-Gesprächsrunden eine Praxisanalyse". Rubigen Bern Ed. Soziothek, 2006. http://www.soziothek.ch?978-3-03796-166-7.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Facchin, Michela Keiser-Grassi Paola. "Cannabis-Gesprächsrunden : eine Praxisanalyse /". Rubigen [u.a.] : Ed. Soziothek, 2007. http://www.soziothek.ch?978-3-03796-166-7.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Lundberg, Malin, i Malin Vennstrand. "Ungdomars riskuppfattning kring cannabis". Thesis, Mittuniversitetet, Avdelningen för samhällsvetenskap, 2014. http://urn.kb.se/resolve?urn=urn:nbn:se:miun:diva-22679.

Pełny tekst źródła
Streszczenie:
Abstrakt Syftet med studien har varit att studera hur unga i åldern 16-20 år i Östersunds kommun förhåller sig till riskerna med cannabis. samt att se hur ungdomar i interaktion med varandra diskuterar, uppfattar och upplever riskerna med cannabis. Studien utgår ifrån ett fenomenologiskt perspektiv och baseras på en enkät och fokusgrupper med gymnasieungdomar i Östersund. Resultatet visar att ungdomarna som deltagit i studien har en viss acceptans till att droger används i deras omgivning och närhet. Det finns också brister i kommunikationen mellan vuxna och ungdomar om riskerna med droganvändning. Utifrån de resultat som framkommit, samt forskningslitteratur på området, har det förts en diskussion kring hur exempelvis skola, polis och andra vuxna på ett bra sätt skulle kunna gå tillväga när de förmedlar riskinformation om droger till ungdomar.
Style APA, Harvard, Vancouver, ISO itp.
10

Cruz, Ana Luísa Mayer Rodrigues Vera. "Cannabis e doença mental". Master's thesis, Universidade da Beira Interior, 2013. http://hdl.handle.net/10400.6/1399.

Pełny tekst źródła
Streszczenie:
Introdução: A Cannabis é a droga ilícita mais usada em todo o mundo. Desde o princípio dos anos 90 a idade de início de consumo tem vindo a decrescer e a prevalência ao longo da vida aumentou na maioria dos países desenvolvidos. Sabe-se que a prevalência do seu consumo é elevada entre os doentes psiquiátricos, o que está associado a um pior prognóstico, com maior resistência à medicação, maior intensidade de sintomas, maiores taxas de recorrência e maior número de hospitalizações. Tem sido estudada a relação entre o abuso de Cannabis e doenças específicas, como as doenças psicóticas, em particular a esquizofrenia, os transtornos do humor, como a doença bipolar e a depressão, a ansiedade, a agressividade, a síndrome amotivacional e também a relação com o abuso de outras substâncias. Objectivos: O principal objectivo deste estudo é caracterizar, a nível de patologia mental, um subgrupo de consumidores de Cannabis que tiveram necessidade de internamento. Metodologia: Foram incluídos no estudo todos os doentes internados no Departamento de Psiquiatria e Saúde Mental da ULS da Guarda entre Janeiro de 2007 e Dezembro de 2012 com o diagnóstico de abuso ou dependência de Cannabis. Resultados: A média de idade de início de consumo foi de 16,1 anos. O tempo decorrido entre o início do consumo e o primeiro episódio de internamento foi em média de 8,9 anos. Encontrou-se uma relação fraca entre a idade de início do consumo e o tempo decorrido até ao primeiro episódio de internamento (r=0,249; p=0,411). Observou-se que os sintomas mais prevalentes foram ideação delirante, humor deprimido, insónia e actividade alucinatória. O diagnóstico mais frequente foi o de esquizofrenia paranóide (30,6%) seguindo-se a psicose induzida por Cannabis (25%) e a depressão (16,7%). Em 44,4% dos indivíduos foi-lhes diagnosticado ao longo da vida o abuso/dependência de outras substâncias, sendo a mais prevalente os opiáceos. Conclusões: Os indivíduos consumidores são na maioria jovens que se iniciaram no abuso de substâncias durante a adolescência, sendo que em muitos casos o início precoce do consumo condiciona patologia mental mais severa. As doenças psicóticas são as mais relacionadas com o consumo de Cannabis e existe uma associação forte com o consumo de outras substâncias.
Introduction: Cannabis is the most used illicit drug worldwide. Since the early 90’s the age of onset of Cannabis consumption has been decreasing and the lifetime prevalence increased in the majority of the developed countries. It is known that the prevalence of its consumption is greater among people with psychiatric disorders, which is associated to poor outcomes, with higher resistance to medication, more severe symptoms, higher relapse rates and higher number of hospitalizations. The relationship between Cannabis abuse and specific disorders like psychosis, in particular schizophrenia, affective disorders like bipolar disorder and depression, anxiety, aggressive behaviors, amotivational syndrome and also the relation with the abuse of other substances. Objectives: The principal aim of this study is to characterize, in a mental health perspective, a subgroup of Cannabis consumer in-patients. Methods: It were admitted to the study all the in-patients of Guarda’s ULS Psychiatry and Mental Health Department between January 2007 and December 2012 with Cannabis abuse or/and dependence diagnosis. Results: The mean age of Cannabis first use was 16,1 years. The time interval between Cannabis initiation and the first hospitalization episode was in average 8,9 years. A relationship between the age at first Cannabis use and the time lapse until the first hospitalization was found (r=0,249, p=0,411). The most prevalent symptoms were delusions, depressive humor, insomnia and hallucinations. The most frequent diagnosis was paranoid schizophrenia (30,6%) followed by Cannabis-induced psychosis (25%) and depression (16,7%). 44,4% of the patients met other substances abuse/dependence criteria, mostly opiates. Conclusions: Cannabis consumers are mostly young people who start consuming it during adolescence, and in the majority of the cases a younger age of onset consuming Cannabis predicts greater severity of mental illness. Psychotic disorders have the strongest association with Cannabis and there is a relationship between the consumption and other substance abuse disorders.
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Książki na temat "Cannabis"

1

Brown, David T. Cannabis: The genus Cannabis. Australia: Harwood Academic Publishers, 1998.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

T, Brown David, red. Cannabis: The genus Cannabis. Amsterdam: Harwood Academic Publishers, 1998.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

T, Brown David, red. Cannabis: The genus Cannabis. Australia: Harwood Academic Publishers, 1998.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Small, Ernest. Cannabis. Boca Raton : Taylor & Francis, 2017.: CRC Press, 2016. http://dx.doi.org/10.1201/9781315367583.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Louis, Betty Wedman-St, red. Cannabis. Boca Raton : Taylor & Francis, 2018.: CRC Press, 2018. http://dx.doi.org/10.1201/9780203730591.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Brown, David T., red. CANNABIS. Abingdon, UK: Taylor & Francis, 1998. http://dx.doi.org/10.4324/9780203304228.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Hayes, Gary. Cannabis. London: ISDD, 1998.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Institute for the Study of Drug Dependence., red. Cannabis. London: ISDD, 1993.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Wanke, Michał, Sveinung Sandberg, Ruken Macit i Hakan Gülerce. Cannabis. London: Routledge, 2024. http://dx.doi.org/10.4324/9781003468967.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Seddon, Toby, i William Floodgate. Regulating Cannabis. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-52927-7.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Części książek na temat "Cannabis"

1

Rodziewicz, Paweł, i Oliver Kayser. "Cannabis sativa L. –Cannabis". W Handbook of Plant Breeding, 233–64. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-38792-1_3.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Khan, JaVed I., Thomas J. Kennedy i Donnell R. Christian. "Cannabis". W Basic Principles of Forensic Chemistry, 145–56. Totowa, NJ: Humana Press, 2011. http://dx.doi.org/10.1007/978-1-59745-437-7_12.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Leweke, F. Markus, i Carolin Hoyer. "Cannabis". W Handbuch der Psychopharmakotherapie, 897–901. Berlin, Heidelberg: Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-19844-1_69.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Rassool, G. Hussein. "Cannabis". W Understanding Addiction Behaviours, 102–14. London: Macmillan Education UK, 2011. http://dx.doi.org/10.1007/978-0-230-34456-3_7.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Beck, C. E. "Cannabis". W Suchtmittel in der AINS, 65–78. Berlin, Heidelberg: Springer Berlin Heidelberg, 2007. http://dx.doi.org/10.1007/978-3-540-33734-8_4.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Huestis, Marilyn A. "Cannabis". W Principles of Forensic Toxicology, 389–448. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-42917-1_24.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Gastpar, Markus, Werner Heinz, Thomas Poehlke i Peter Raschke. "Cannabis". W Glossar: Substitutionstherapie bei Drogenabhängigkeit, 30–31. Berlin, Heidelberg: Springer Berlin Heidelberg, 1998. http://dx.doi.org/10.1007/978-3-662-07502-9_19.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Moreland-Capuia, Alisha. "Cannabis". W Training for Change, 147–71. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-19208-2_5.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Peter, Helga, i Thomas Penzel. "Cannabis". W Springer Reference Medizin, 1. Berlin, Heidelberg: Springer Berlin Heidelberg, 2020. http://dx.doi.org/10.1007/978-3-642-54672-3_377-1.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Latt, Noeline, Katherine Conigrave, John B. Saunders, E. Jane Marshall i David Nutt. "Cannabis". W Medicina delle dipendenze, 197–208. Milano: Springer Milan, 2014. http://dx.doi.org/10.1007/978-88-470-2883-8_7.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Streszczenia konferencji na temat "Cannabis"

1

Guay, Paul, Maha Mian, Brianna Altman, Luna Ueno i Mitch Earleywine. "Anxiety, Expectancies for Cannabis-Induced Anxiolytic Effects, and Frequency of Cannabis Consumption". W 2020 Virtual Scientific Meeting of the Research Society on Marijuana. Research Society on Marijuana, 2021. http://dx.doi.org/10.26828/cannabis.2021.01.000.36.

Pełny tekst źródła
Streszczenie:
This study explored relations among anxiety, expectancies for cannabis’s anxiolytic effects, and frequency of use. Undergraduate users (N=242, Mage = 19.1, 64.5% male, 46.6% White, 18.6% African American, 13% Hispanic/Latino, 12.7% Asian, 9.1% Mixed) rated their anxiety on the TSC-40. They reported expectancies for cannabis’s anxiolytic effects using the same TSC items with a rating from -2 (making the symptom worse) to +2 (making the symptom better). Average expectancies were 2.41, suggesting that users expected some impact of cannabis on anxiety symptoms. These expectancies showed a dramatic skew that required transformation. We regressed anxiety and expectancies and their centered interaction term on days of use per month. Expectancies (B=.917) served as a significant predictor, however anxiety did not (B=.215). The interaction term was not significant, (B=.155). These results suggest that users choose the number of days they use based on their expectations of cannabis-induced improvement of anxiety, not on their level of anxiety. The interaction was not an important contributor. These results suggest that alternative approaches for handling anxiety might decrease the frequency of cannabis consumption. In addition, challenging cannabis expectancies about anxiety could also decrease frequency of consumption.
Style APA, Harvard, Vancouver, ISO itp.
2

El Khattabi, Wiam, Loubna Qassimi, Hasna Jabri i Hicham Afif. "Comparative study on lung cancer cannabis subjects, not cannabis". W Annual Congress 2015. European Respiratory Society, 2015. http://dx.doi.org/10.1183/13993003.congress-2015.pa1880.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

"CANNABIS Y EMBARAZO". W PATOLOGIA_DUAL_2023. SEPD, 2023. http://dx.doi.org/10.17579/libro_comunicacionessepd2023.p-216.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Tan, Zachary, i Victor Morris. "348 Cannabis baby". W 10th Europaediatrics Congress, Zagreb, Croatia, 7–9 October 2021. BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health, 2021. http://dx.doi.org/10.1136/archdischild-2021-europaediatrics.348.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Noack, M. "Cannabis und ADHS". W Deutscher Suchtkongress 2019. Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0039-1696200.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

"CANNABIS Y PSICOSIS". W 8th World Congress of the World Association of Dual Disorders (WADD) and the 26th Congress of the Spanish Society of Dual Disorders SEPD. SEPD/WADD, 2024. http://dx.doi.org/10.17579/abstractbookdualdisorders-p-179.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

"PSICOSIS Y CANNABIS". W 8th World Congress of the World Association of Dual Disorders (WADD) and the 26th Congress of the Spanish Society of Dual Disorders SEPD. SEPD/WADD, 2024. http://dx.doi.org/10.17579/abstractbookdualdisorders-p-118.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Samasutthi, Pranpreya, i Chutiporn Anutariya. "CannabisO: The Ontology-based Knowledge Model for Safe Cannabis Consumption in Thailand". W 2023 20th International Joint Conference on Computer Science and Software Engineering (JCSSE). IEEE, 2023. http://dx.doi.org/10.1109/jcsse58229.2023.10202087.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Castro, Michelle, Ricarda Pritschmann, Meredith Berry, Richard Yi i Ali Yurasek. "Associations of Cannabis Use Motives and Cannabis Demand in Young Adults". W 2021 Virtual Scientific Meeting of the Research Society on Marijuana. Research Society on Marijuana, 2022. http://dx.doi.org/10.26828/cannabis.2022.01.000.02.

Pełny tekst źródła
Streszczenie:
Background: Cannabis is the most commonly used illicit substance among young adults and is associated with a variety of negative consequences. Studies have shown that both cannabis demand and certain cannabis motives are associated with higher levels and frequency of cannabis use, as well as associated problems. No study has yet to examine the relationship between cannabis use motives and cannabis demand. The purpose of the current study was to examine the associations between individual cannabis motives and cannabis demand. Methods: Data were collected from 95 young adult cannabis users who reported using cannabis at least once in the last 30 days. (M age = 20.63; Female = 50.5%; M cannabis use days per month = 14.64). Participants completed questionnaires assessing cannabis use frequency, cannabis use motives, and a cannabis purchase task. Amplitude, representative of the amount consumed at an unrestricted price, and persistence, representative of sensitivity to escalating price, were calculated and used in the analyses. Results: Initial correlational analyses demonstrated significant relationships between demand and total number of cannabis motives and conformity, enjoyment, coping, experimentation, boredom, celebration, and sleep motives (ps < .05). A series of hierarchical linear regressions were conducted to determine the specific associations between the aforementioned individual cannabis motives and amplitude and persistence. Step one controlled for age, gender, and cannabis use frequency, and the motives were added in step two. Regression models indicated that total number of motives, enjoyment, conformity, and coping motives were significant predictors of persistence even after controlling for cannabis use frequency. Motives were not significant predictors of amplitude. Conclusion: Findings from this study suggest that young adults who use cannabis for enjoyment, conformity, or coping reasons may experience greater reinforcement efficacy of cannabis which may place them at increased risk to develop cannabis use disorder or other related problems associated with their use. Further, young adults with these cannabis use motives may be less sensitive to increases in price and continue to purchase cannabis at higher prices. These findings can be used to inform cannabis interventions by targeting specific motives for use.
Style APA, Harvard, Vancouver, ISO itp.
10

Dunn, Delaney, Sarah Ehlke, Michael Smith, Darla Kendzor i Amy Cohn. "Responses to Recreational Cannabis Legalization among Non-Users, Cannabis Users without a License and Cannabis Users with a License". W 2022 Annual Scientific Meeting of the Research Society on Marijuana. Research Society on Marijuana, 2022. http://dx.doi.org/10.26828/cannabis.2022.02.000.48.

Pełny tekst źródła
Streszczenie:
Significance: With the changing cannabis legalization landscape, it is important to assess how people may respond to new cannabis legalization policies to inform the effectiveness of such policies that balance public health with consumer needs and interests. Recent research compared intentions to use legalized cannabis among young adult never and ever cannabis users (Leung et al., 2020) and found 59% of never users and 41% of ever users intended to try cannabis if it were legal. However, past research has not examined differences in cannabis use intentions among different groups who report using cannabis for medical reasons versus non-medical reasons, even though past research has demonstrated the importance of differentiating the two groups (Roy-Byrne et al., 2015). As such, the present study aims to assess the unique correlates of responses to cannabis legalization across non-users, cannabis users without a license and cannabis users with a license. Method: Participants were adults living in Oklahoma (verified by self-reported zip code of residence) who participated in one wave of a 3-wave cross-sectional online survey (N = 5,248; 63.7%, non-past 30-day users, 15.8%, past 30-day cannabis users without a medical cannabis license, 17.8%, past 30-day cannabis users with a license) with an average age of 40.35 years. Participants were female (56.8%) and non-Hispanic White (70.3%). Participants completed measures related to past 30-day cannabis use, procession of a cannabis license, and were asked to “select all that apply” to a single item with 8 response options about how they would respond if recreational cannabis was legalized in their state. Results: Multivariable logistic regression models revealed significant differences in all 7 of the response options analyzed among non-users, cannabis users without a license and cannabis users with a license controlling for demographic characteristics (ps < .05; the 8th item “would use it less” was not assessed among non-users). Next, logistic regression models were examined in all 8 of the response options to compare cannabis users with a license and cannabis users without a license. Cannabis users with a license were more likely to report they would recommend cannabis to a friend or family member (AOR = 1.32, 95%CI: 1.04, 1.68), and they would use cannabis the same as they do now (AOR = 1.75, 95%CI: 1.43, 2.15). In contrast, cannabis users without a license were more likely to report they would use cannabis more than they do now (AOR = .44, 95%CI: 0.34, 0.57), they would use other types of cannabis (AOR = .62, 95%CI: 0.47, 0.80), and they would use cannabis more often to help treat their symptoms (AOR = .60, 95%CI: 0.47, 0.77). Conclusion: Findings support evidence of differences in how groups would respond to non-medical cannabis legalization with cannabis users without a license intending to use more cannabis. This greater use could become problematic as cannabis strands become more potent with non-medical legalization (Shover & Humphreys, 2019). Future research should continue to examine responses to non-medical cannabis legalization to inform cannabis harm prevention and policy changes related to legalizing non-medical cannabis.
Style APA, Harvard, Vancouver, ISO itp.

Raporty organizacyjne na temat "Cannabis"

1

Barber, Chuck. Cannabis Quality Assurance Program:. Gaithersburg, MD: National Institute of Standards and Technology, 2022. http://dx.doi.org/10.6028/nist.ir.8449.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Bryan Sallee, Colleen E. Cannabis Quality Assurance Program:. Gaithersburg, MD: National Institute of Standards and Technology, 2022. http://dx.doi.org/10.6028/nist.ir.8452.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Drake, Coleman, Dylan Nagy, Matthew Eisenberg i David Slusky. Medical Cannabis Availability and Mental Health: Evidence From New York’s Medical Cannabis Program. Cambridge, MA: National Bureau of Economic Research, maj 2024. http://dx.doi.org/10.3386/w32514.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Yarberry, Andrea J. Cannabis Laboratory Quality Assurance Program:. Gaithersburg, MD: National Institute of Standards and Technology, 2024. http://dx.doi.org/10.6028/nist.ir.8519.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Cushing, Donish, Bomi Joseph, Ravi Shastri i Ravi Kristipati. Measuring the bioactivity of phytocannabinoid cannabidiol from cannabis sources, and a novel non-cannabis source. Peak Health Center, maj 2018. http://dx.doi.org/10.31013/1002b.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Cushing, Donish, Bomi Joseph, Ravi Kristipati i Ravi Shastri. Measuring the bioactivity of phytocannabinoid cannabidiol from cannabis sources, and a novel non-cannabis source. Peak Health Center, maj 2018. http://dx.doi.org/10.31013/2002b.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Dutra, Lauren M., Matthew C. Farrelly, Brian Bradfield, Jamie Ridenhour i Jamie Guillory. Modeling the Probability of Fraud in Social Media in a National Cannabis Survey. RTI Press, wrzesień 2021. http://dx.doi.org/10.3768/rtipress.2021.mr.0046.2109.

Pełny tekst źródła
Streszczenie:
Cannabis legalization has spread rapidly in the United States. Although national surveys provide robust information on the prevalence of cannabis use, cannabis disorders, and related outcomes, information on knowledge, attitudes, and beliefs (KABs) about cannabis is lacking. To inform the relationship between cannabis legalization and cannabis-related KABs, RTI International launched the National Cannabis Climate Survey (NCCS) in 2016. The survey sampled US residents 18 years or older via mail (n = 2,102), mail-to-web (n = 1,046), and two social media data collections (n = 11,957). This report outlines two techniques that we used to problem-solve several challenges with the resulting data: (1) developing a model for detecting fraudulent cases in social media completes after standard fraud detection measures were insufficient and (2) designing a weighting scheme to pool multiple probability and nonprobability samples. We also describe our approach for validating the pooled dataset. The fraud prevention and detection processes, predictive model of fraud, and the methods used to weight the probability and nonprobability samples can be applied to current and future complex data collections and analysis of existing datasets.
Style APA, Harvard, Vancouver, ISO itp.
8

Nielsen, Suzanne. Evidence lacking on medical cannabis for pain. Redaktor Charis Palmer. Monash University, grudzień 2022. http://dx.doi.org/10.54377/7111-9694.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Barrus, Daniel, Kristen Capogrossi, Sheryl Cates, Camille Gourdet, Nicholas Peiper, Scott Novak, Timothy Lefever i Jenny Wiley. Tasty THC: Promises and Challenges of Cannabis Edibles. RTI Press, listopad 2016. http://dx.doi.org/10.3768/rtipress.2016.op.0035.1611.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Abdur-Rahman, Maryam, Melissa M. Phillips i Walter B. Wilson. Cannabis Quality Assurance Program: Exercise 1 Final Report. National Institute of Standards and Technology, lipiec 2021. http://dx.doi.org/10.6028/nist.ir.8385.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Możesz być także zainteresowany rozszerzonymi bibliografiami na temat „Cannabis” dla poszczególnych typów źródeł:
Artykuły w czasopismach Rozprawy doktorskie Książki
Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!

Do bibliografii